These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1265588)
1. [Treatment of thalasemia major with a multiple transfusion schedule (author's transl)]. Celada A; Herreros V; Wyss M Sangre (Barc); 1976; 21(1):25-31. PubMed ID: 1265588 [No Abstract] [Full Text] [Related]
2. Spleen iron content is low in thalassemia. Borgna-Pignatti C; De Stefano P; Bongo IG; Avato F; Cazzola M Am J Pediatr Hematol Oncol; 1984; 6(3):340-3. PubMed ID: 6517228 [TBL] [Abstract][Full Text] [Related]
3. [Nuclear magnetic resonance and iron overload in thalassemia]. Schettini F; De Mattia D; Cavallo L; Sabato V; Santoro N; Del Vecchio GC; Martinelli G; Martinelli A; Di Bartolomeo P; Di Girolamo G Minerva Pediatr; 1991 Dec; 43(12):777-81. PubMed ID: 1798402 [TBL] [Abstract][Full Text] [Related]
4. Iron balance in thalassemia. Cazzola M; Finch CA Prog Clin Biol Res; 1989; 309():93-100. PubMed ID: 2675109 [No Abstract] [Full Text] [Related]
5. Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives. Cantore N; Tortarolo M; Volpe E; Gonnella F; Valente A; Buonanno G Haematologica; 1981 Apr; 66(2):196-207. PubMed ID: 6791996 [No Abstract] [Full Text] [Related]
12. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously]. Ferrara M; Galdo Capotorti M; Ponte G; Esposito L Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400 [No Abstract] [Full Text] [Related]
13. [Effects of desferrioxamine on iron elimination in children after multiple transfusions]. Leggio ML Minerva Pediatr; 1966 Feb; 18(3):101-3. PubMed ID: 5930397 [No Abstract] [Full Text] [Related]
15. [Post-transfusion multiple isoantibodies in a girl with thalassemia major]. Centa A; Marchi AG Minerva Pediatr; 1968 Mar; 20(10):518-21. PubMed ID: 5739011 [No Abstract] [Full Text] [Related]
16. [Chelating therapy in beta-thalassemia]. Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040 [TBL] [Abstract][Full Text] [Related]
17. Iron metabolism and iron chelation in the thalassaemia disorders. Pippard MJ Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383 [No Abstract] [Full Text] [Related]
18. High nontransferrin bound iron levels and heart disease in thalassemia major. Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228 [TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis C virus infection in thalassemia. Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677 [TBL] [Abstract][Full Text] [Related]
20. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]